{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:40:28Z","timestamp":1784371228712,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.msec.2016.02.062","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T06:27:33Z","timestamp":1456208853000},"page":"78-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Risedronate\/zinc-hydroxyapatite based nanomedicine for osteoporosis"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3737-8504","authenticated-orcid":false,"given":"Deepak Kumar","family":"Khajuria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choudhary","family":"Disha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishna","family":"Vasireddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rema","family":"Razdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Roy","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.msec.2016.02.062_bb0005","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.msec.2016.02.062_bb0010","first-page":"365","article-title":"Drugs for the management of osteoporosis: a review","volume":"51","author":"Khajuria","year":"2011","journal-title":"Rev. Bras. Reumatol."},{"issue":"11","key":"10.1016\/j.msec.2016.02.062_bb0015","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3181\/0803-RM-93","article-title":"Methanolic extract of Cuminum cyminum inhibits ovariectomy-induced bone loss in rats","volume":"233","author":"Shirke","year":"2008","journal-title":"Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.msec.2016.02.062_bb0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14310\/horm.2002.1226","article-title":"Bisphosphonate-associated adverse events","volume":"8","author":"Papapetrou","year":"2009","journal-title":"Hormones"},{"key":"10.1016\/j.msec.2016.02.062_bb0025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.msec.2013.11.009","article-title":"Biomimetic magnesium\u2013carbonate-apatite nanocrystals endowed with strontium ions as anti-osteoporotic trigger","volume":"35","author":"Iafisco","year":"2014","journal-title":"Mater. Sci. Eng. C"},{"issue":"2","key":"10.1016\/j.msec.2016.02.062_bb0030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jbm.a.31994","article-title":"Study of hydroxyapatite osteoinductivity with an osteogenic 257 differentiation of mesenchymal stem cells","volume":"89","author":"Lin","year":"2009","journal-title":"J. Biomed. Mater. Res. A."},{"issue":"17","key":"10.1016\/j.msec.2016.02.062_bb0035","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0142-9612(00)00075-2","article-title":"Enhanced functions of 442 osteoblasts on nanophase ceramics","volume":"21","author":"Webster","year":"2000","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.msec.2016.02.062_bb0040","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/j.transproceed.2008.07.096","article-title":"The upregulation of osteoblast marker genes in mesenchymal stem cells prove the osteoinductivity of hydroxyapatite\/tricalcium phosphate biomaterial","volume":"40","author":"Sun","year":"2008","journal-title":"Transplant. Proc."},{"issue":"2","key":"10.1016\/j.msec.2016.02.062_bb0045","first-page":"1","article-title":"Improvement in bone properties by risedronate adsorbed hydroxyapatite novel nanoparticle formulation in rat model of postmenopausal osteoporosis","volume":"9","author":"Sahana","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"issue":"23","key":"10.1016\/j.msec.2016.02.062_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2014.10.015","article-title":"Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model","volume":"66","author":"Khajuria","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.msec.2016.02.062_bb0055","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10856-007-3213-4","article-title":"Structural characterization of zinc-substituted hydroxyapatite prepared by hydrothermal method","volume":"19","author":"Li","year":"2008","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"1\u20132","key":"10.1016\/j.msec.2016.02.062_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11010-009-0358-0","article-title":"Role of nutritional zinc in the prevention of osteoporosis","volume":"338","author":"Yamaguchi","year":"2010","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.msec.2016.02.062_bb0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ajcn\/51.2.225","article-title":"Zinc toxicity","volume":"51","author":"Fosmire","year":"1990","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.msec.2016.02.062_bb0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cap.2004.10.006","article-title":"Zinc-containing tricalcium phosphate and related materials for promoting bone formation","volume":"5","author":"Ito","year":"2005","journal-title":"Curr. Appl. Phys."},{"issue":"17","key":"10.1016\/j.msec.2016.02.062_bb0075","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.biomaterials.2006.01.024","article-title":"Influence of the zinc concentration of sol\u2013gel derived zinc substituted hydroxyapatite on cytokine production by human monocytes in vitro","volume":"27","author":"Grandjean-Laquerriere","year":"2006","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.msec.2016.02.062_bb0080","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.biomaterials.2003.09.001","article-title":"Osteoblast response to hydroxyapatite doped with divalent and trivalent cations","volume":"25","author":"Webster","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.msec.2016.02.062_bb0085","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1179\/026708304225019704","article-title":"Zinc containing hydroxyapatite ceramics to promote osteoblastic cell activity","volume":"20","author":"Sogo","year":"2004","journal-title":"Mater. Sci. Technol."},{"issue":"2","key":"10.1016\/j.msec.2016.02.062_bb0090","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jbm.a.31265","article-title":"Inhibitory effect of Zn2+ in zinc-containing b-tricalcium phosphate on resorbing activity of mature osteoclasts","volume":"84","author":"Yamada","year":"2008","journal-title":"J. Biomed. Mater. Res. A."},{"issue":"3","key":"10.1016\/j.msec.2016.02.062_bb0095","first-page":"173","article-title":"Nanocrystalline hydroxyapatite and zinc-doped hydroxyapatite as carrier material for controlled delivery of ciprofloxacin, 3","volume":"1","author":"Venkatasubbu","year":"2011","journal-title":"Biotechonology"},{"issue":"21","key":"10.1016\/j.msec.2016.02.062_bb0100","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2174\/1381612023393585","article-title":"Bisphosphonates as a foundation of drug delivery to bone","volume":"8","author":"Uludag","year":"2002","journal-title":"Curr. Pharm. Des."},{"issue":"20 Pt 2","key":"10.1016\/j.msec.2016.02.062_bb0105","doi-asserted-by":"crossref","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: current status","volume":"12","author":"Roelofs","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.msec.2016.02.062_bb0110","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1248\/bpb.34.1215","article-title":"Effect of zinc-containing \u03b2-tricalcium phosphate nano particles injection on jawbone mineral density and mechanical strength of osteoporosis model rats","volume":"34","author":"Tokudome","year":"2011","journal-title":"Biol. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.msec.2016.02.062_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071821","article-title":"The therapeutic effect on bone mineral formation from biomimetic zinc containing tricalcium phosphate (ZnTCP) in zinc-deficient osteoporotic mice","volume":"8","author":"Chou","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msec.2016.02.062_bb0120","first-page":"257","article-title":"Development of zinc doped hydroxyapatite for bone implant applications","volume":"F (24)","author":"Norhidayu","year":"2008","journal-title":"ICCBT"},{"issue":"3","key":"10.1016\/j.msec.2016.02.062_bb0125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1590\/S0482-50042012000300016","article-title":"Description of a new method of ovariectomy in female rats","volume":"52","author":"Khajuria","year":"2012","journal-title":"Rev. Bras. Reumatol."},{"issue":"1","key":"10.1016\/j.msec.2016.02.062_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/clinchem\/47.1.74","article-title":"Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity","volume":"47","author":"Janckila","year":"2001","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.msec.2016.02.062_bb0135","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s00776-013-0433-y","article-title":"Osteoprotective effect of propranolol in ovariectomized rats: a comparison with zoledronic acid and alfacalcidol","volume":"18","author":"Khajuria","year":"2013","journal-title":"J. Orthop. Sci."},{"issue":"2","key":"10.1016\/j.msec.2016.02.062_bb0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3797\/scipharm.1310-06","article-title":"Prophylactic effects of propranolol versus standard therapy on a new model of disuse osteoporosis in rats","volume":"82","author":"Khajuria","year":"2014","journal-title":"Sci. Pharm."},{"issue":"2","key":"10.1016\/j.msec.2016.02.062_bb0145","first-page":"100","article-title":"Royal jelly and bee pollen decrease bone loss due to osteoporosis in an oophorectomized rat model","volume":"23","author":"Kafadar","year":"2012","journal-title":"Eklem Hastalik Cerrahisi"},{"issue":"1","key":"10.1016\/j.msec.2016.02.062_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jascer.2014.01.005","article-title":"Animal trial on zinc doped hydroxyapatite: a case study","volume":"2","author":"Bhattacharjee","year":"2014","journal-title":"J. Asian Ceram. Soc."},{"issue":"1","key":"10.1016\/j.msec.2016.02.062_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11051-007-9239-1","article-title":"Exploiting the high-affinity phosphonate\u2013hydroxyapatite nanoparticle interaction for delivery of radiation and drugs","volume":"10","author":"Ong","year":"2008","journal-title":"J. Nanoparticle Res."},{"issue":"7","key":"10.1016\/j.msec.2016.02.062_bb0160","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1021\/la903617e","article-title":"Zn- and Mg-doped hydroxyapatite nanoparticles for controlled release of protein","volume":"26","author":"Dasgupta","year":"2010","journal-title":"Langmuir"},{"issue":"4","key":"10.1016\/j.msec.2016.02.062_bb0165","first-page":"97","article-title":"Biochemical markers of bone turnover: part I: biochemistry and variability","volume":"26","author":"Seibel","year":"2005","journal-title":"Clin. Biochem. Rev."},{"issue":"2","key":"10.1016\/j.msec.2016.02.062_bb0170","first-page":"210","article-title":"Evidence for a prospective antiosteoporosis effect of black tea (Camellia sinensis) extract in a bilaterally ovariectomized rat model","volume":"13","author":"Das","year":"2004","journal-title":"Asia Pac. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.msec.2016.02.062_bb0175","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.3390\/ijms13033431","article-title":"Dietary pseudopurpurin effects on bone mineral density and bone geometry architecture in rats","volume":"13","author":"Wu","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msec.2016.02.062_bb0180","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/xrs.2551","article-title":"Evaluation of CT-DEA performance on Ca\/P ratio assessment in bone apatite using EDX","volume":"43","author":"Hadjipanteli","year":"2014","journal-title":"X-Ray Spectrom."},{"issue":"4","key":"10.1016\/j.msec.2016.02.062_bb0185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/biof.1163","article-title":"Role of trace elements (Zn, Sr, Fe) in bone development: energy dispersive X-ray fluorescence study of rat bone and tooth tissue","volume":"40","author":"Maciejewska","year":"2014","journal-title":"Biofactors"},{"key":"10.1016\/j.msec.2016.02.062_bb0190","first-page":"136","article-title":"Energy-dispersive X-ray microanalysis of the bone mineral content in human trabecular bone: a comparison with ICPES and neutron activation analysis","volume":"155","author":"Akesson","year":"1994","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.msec.2016.02.062_bb0195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/bonekey.2013.181","article-title":"Bone composition: relationship to bone fragility and antiosteoporotic drug effects","volume":"2","author":"Boskey","year":"2013","journal-title":"BoneKEy Rep."}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493116301540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493116301540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T23:42:42Z","timestamp":1600213362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493116301540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":39,"alternative-id":["S0928493116301540"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2016.02.062","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risedronate\/zinc-hydroxyapatite based nanomedicine for osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2016.02.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}